Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
Year: 2013
Type: review
Abstract: Intracellular concentrations of drugs and metabolites are often important determinants of efficacy, toxicity, and drug interactions. Hepatic drug distribution can be affected by many factors, including physicochemical properties, uptake/efflux transporters, protein binding, organelle sequestration, and metabolism. This white paper highlights determinants of hepatocyte drug/metabolite concentrations and provides an update on model systems, methods, and modeling/simulation approaches used to quantitatively assess hepatocellular concentrations of molecules. The critical scientific gaps and future research directions in this field are discussed.
DOI: 10.1038/clpt.2013.78
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Temple University, AstraZeneca (United Kingdom), University of Manchester, Pfizer (United States), Bristol-Myers Squibb (United States), Uppsala University, Seagen (United States), University of Michigan, United States Food and Drug Administration, Center for Drug Evaluation and Research, GlaxoSmithKline (United States), RIKEN, University of North Carolina at Chapel Hill
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2021233291
